Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.

Science (New York, N.Y.) | Jun 21, 2002

Huntington's disease (HD) is an inherited neurodegenerative disease caused by expansion of a polyglutamine tract in the huntingtin protein. Transcriptional dysregulation has been implicated in HD pathogenesis. Here, we report that huntingtin interacts with the transcriptional activator Sp1 and coactivator TAFII130. Coexpression of Sp1 and TAFII130 in cultured striatal cells from wild-type and HD transgenic mice reverses the transcriptional inhibition of the dopamine D2 receptor gene caused by mutant huntingtin, as well as protects neurons from huntingtin-induced cellular toxicity. Furthermore, soluble mutant huntingtin inhibits Sp1 binding to DNA in postmortem brain tissues of both presymptomatic and affected HD patients. Understanding these early molecular events in HD may provide an opportunity to interfere with the effects of mutant huntingtin before the development of disease symptoms.

Pubmed ID: 11988536 RIS Download

Mesh terms: Animals | Brain | Caudate Nucleus | Cell Death | Cell Line | Cell Nucleus | Cells, Cultured | Corpus Striatum | DNA | DNA-Binding Proteins | Down-Regulation | Gene Expression Regulation | Humans | Huntingtin Protein | Huntington Disease | Mice | Mice, Transgenic | Mutation | Nerve Tissue Proteins | Neurons | Nuclear Proteins | Peptides | Promoter Regions, Genetic | Rats | Receptors, Dopamine D2 | Solubility | Sp1 Transcription Factor | TATA-Binding Protein Associated Factors | Transcription Factor TFIID | Transcription Factors | Transcription, Genetic | Transfection | Trinucleotide Repeat Expansion | Two-Hybrid System Techniques

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIA NIH HHS, Id: 5R37AG13617
  • Agency: NCCIH NIH HHS, Id: AT00613
  • Agency: NINDS NIH HHS, Id: NS02174
  • Agency: NINDS NIH HHS, Id: NS34361
  • Agency: NINDS NIH HHS, Id: NS35255

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.